
URGN
Healthcare · Biotechnology · $1.28B market cap
$26.18-0.21 (-0.8%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +14.9% over 90 days · 30-day revisions 5 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 4, 2026 | Before the open | 0.05 | -0.03 | -160.0% |
| Aug 5, 2026 | Before the open | -0.38 | -0.28 | +26.3% |
| May 6, 2026 | Before the open | -0.48 | -0.47 | +2.1% |
| Mar 2, 2026 | Time not confirmed | -0.48 | -0.53 | -9.9% |
| Nov 6, 2025 | Before the open | -0.68 | -0.69 | -1.5% |
| Aug 7, 2025 | Before the open | -0.82 | -1.05 | -28.0% |
| May 12, 2025 | Before the open | -0.79 | -0.92 | -16.5% |
| Mar 12, 2025 | Before the open | -0.72 | -0.80 | -11.1% |
| Nov 6, 2024 | Before the open | -0.82 | -0.55 | +32.9% |
| Aug 13, 2024 | Before the open | -0.83 | -0.91 | -9.6% |
| May 13, 2024 | Before the open | -0.87 | -0.97 | -11.5% |
| Mar 14, 2024 | Before the open | -0.68 | -0.72 | -5.9% |
| Nov 14, 2023 | Before the open | -0.87 |
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology; Mitomycin a generic drug used off-label as an adjuvant chemotherapy for the treatment of low-grade NMIBC after trans-urethral resection of bladder tumor; Zusduri, a…
| -0.68 |
| +21.8% |
| Aug 10, 2023 | Before the open | -1.14 | -1.03 | +9.6% |
| May 11, 2023 | Before the open | -1.24 | -1.30 | -4.8% |
| Mar 16, 2023 | Before the open | -1.07 | -1.22 | -14.0% |
| Nov 10, 2022 | Before the open | -1.14 | -1.13 | +0.9% |
| Aug 11, 2022 | Before the open | -1.33 | -1.18 | +11.3% |
| May 10, 2022 | Before the open | -1.25 | -1.25 | 0.0% |
| Mar 21, 2022 | Before the open | -1.17 | -1.27 | -8.5% |
| Nov 15, 2021 | Before the open | -1.33 | -1.35 | -1.5% |
| Aug 4, 2021 | Before the open | -1.09 | -1.17 | -7.3% |
| May 13, 2021 | Before the open | -1.25 | -1.17 | +6.4% |
| Mar 18, 2021 | Before the open | -1.37 | -1.38 | -0.7% |
| Nov 9, 2020 | Before the open | -1.47 | -1.31 | +10.9% |
| Aug 10, 2020 | Before the open | -1.52 | -1.44 | +5.3% |
| May 7, 2020 | Before the open | -1.62 | -1.79 | -10.5% |
| Mar 2, 2020 | Before the open | -1.70 | -1.86 | -9.4% |
| Nov 12, 2019 | Before the open | -1.28 | -1.06 | +17.2% |
| Aug 9, 2019 | Before the open | -1.20 | -1.08 | +10.0% |
| May 9, 2019 | Before the open | -1.26 | -1.11 | +11.9% |
| Feb 28, 2019 | Before the open | -1.24 | -1.46 | -17.7% |
| Nov 12, 2018 | Before the open | -1.11 | -1.28 | -15.3% |
| Aug 14, 2018 | Before the open | -0.93 | -1.14 | -22.6% |
| May 15, 2018 | Before the open | -0.72 | -0.88 | -22.2% |
| Mar 15, 2018 | Before the open | -0.64 | -0.74 | -15.6% |